- Home
- KG vs HCM Comparison
KG vs HCM Comparison
Compare KG & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KG
- HCM
- Stock Information
- Founded
- KG N/A
- HCM 2000
- Country
- KG Bermuda
- HCM Hong Kong
- Employees
- KG N/A
- HCM N/A
- Industry
- KG Property-Casualty Insurers
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- KG Finance
- HCM Health Care
- Exchange
- KG Nasdaq
- HCM Nasdaq
- Market Cap
- KG 2.5B
- HCM 2.5B
- IPO Year
- KG N/A
- HCM N/A
- Fundamental
- Price
- KG $25.79
- HCM $15.41
- Analyst Decision
- KG
- HCM Hold
- Analyst Count
- KG 0
- HCM 1
- Target Price
- KG N/A
- HCM $19.00
- AVG Volume (30 Days)
- KG 44.8K
- HCM 85.9K
- Earning Date
- KG 08-15-2025
- HCM 07-30-2025
- Dividend Yield
- KG N/A
- HCM N/A
- EPS Growth
- KG N/A
- HCM N/A
- EPS
- KG N/A
- HCM 0.04
- Revenue
- KG $5,462,137.00
- HCM $630,201,000.00
- Revenue This Year
- KG N/A
- HCM $14.86
- Revenue Next Year
- KG N/A
- HCM $19.54
- P/E Ratio
- KG $607.37
- HCM $70.47
- Revenue Growth
- KG 250.18
- HCM N/A
- 52 Week Low
- KG $20.51
- HCM $11.51
- 52 Week High
- KG $36.80
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- KG N/A
- HCM 51.55
- Support Level
- KG N/A
- HCM $14.86
- Resistance Level
- KG N/A
- HCM $16.00
- Average True Range (ATR)
- KG 0.00
- HCM 0.35
- MACD
- KG 0.00
- HCM -0.14
- Stochastic Oscillator
- KG 0.00
- HCM 21.52
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.